ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Biotechnology

ADC Therapeutics

Ameet Mallik

David Ellis

Tim Gillum

Jason Moss

Alan S.

Ruchi Mallya

Niall McConnell

Jesse Stromeyer

Stephen Dudek

Jay Feingold

Lisa Källebo

Jada Baijnath

Michelle Celones

Mohamed Zaki

Kristen Harrington-Smith

Jose Carmona

Kimberly Pope

Peter Graham

Patrick van Berkel

Michael Mulkerrin

Leadership Team

Clinical Operations and Development

Finance and Accounting

Teams at ADC Therapeutics

Leadership Team

Clinical Operations and Development

Finance and Accounting